COMPASS Pathways joins the Psychiatry Consortium in a collaboration to accelerate drug discovery in mental health care

London, UK – 9 November 2020 COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company…

Investors: If you like Compass Pathways you will love M2Bio Sciences.

For several weeks now, no one can dispute that the psychedelics market is one of the…

Psychedelic highlights | September 21 – 25

Psychedelic highlights | September 21 – 25 1. COMPASS Pathways | CMPS can’t be stopped and…

COMPASS Pathways announces closing of initial public offering of American Depositary Shares and full exercise of underwriters’ option to purchase additional American Depositary Shares

COMPASS Pathways announces closing of initial public offering of American Depositary Shares and full exercise of…

Psychedelic highlights | Sept. 14 – 18

Psychedelic highlights | September 14 – 18 1. COMPASS Pathways | CMPS enter the market with…

COMPASS Pathways announces pricing of upsized initial public offering

COMPASS Pathways announces pricing of upsized initial public offering London, UK – September 18, 2020 COMPASS Pathways plc (Nasdaq:…